Thereafter, identification of the ETV6-NTRK3 translocation has become a useful diagnostic marker for IFS/CMN, and the presence of this gene fusion is considered pathognomonic for these two rare cancers. The gene discussed is NTRK3; the disease is congenital mesoblastic nephroma.